SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Cantor Fitzgerald Maintains Overweight on Novavax, Raises Price Target to $45

Cantor Fitzgerald maintains Novavax (NASDAQ:NVAX) with a Overweight and raises the price target from $23 to $45.

Benzinga · 05/12/2020 15:01

Cantor Fitzgerald maintains Novavax (NASDAQ:NVAX) with a Overweight and raises the price target from $23 to $45.